Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea.
Research context
Hana Pharm Co., Ltd appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Hana Pharm Co., Ltd is currently in a long term downtrend where the price is trading 7.0% below its 200 day moving average.
From a valuation standpoint, the stock is 74.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Hana Pharm Co., Ltd's total revenue rose by 10.7% to $49B since the same quarter in the previous year.
Its net income has dropped by 160.8% to $-4B since the same quarter in the previous year.
Finally, its free cash flow fell by 223.5% to $-6B since the same quarter in the previous year.
Based on the above factors, Hana Pharm Co., Ltd gets an overall score of 2/5.